 | Immunome, Inc. | |||
| NCM : IMNM || Location: United States | ||||
$14.27-0.39 (-2.66%) |
0.56 M | 14.2 - 14.92 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 3.241 M |
| March 15, 2024 | 3.009 M |
| Feb. 29, 2024 | 2.650 M |
| Feb. 15, 2024 | 3.848 M |
| Jan. 31, 2024 | 3.409 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.29 | -4.22 | -1360.21% |
| 06/30/2023 | -0.16 | -0.46 | -181.86% |
| 03/31/2023 | 0.60 | -0.35 | -158.66% |
| 12/31/2022 | -0.69 | -0.64 | 7.04% |
| 09/30/2022 | -0.78 | -0.75 | 3.25% |
IMNM Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 59.694M | Shares Float | 44.035M |
| Short Float | 3.241M | Market Cap | 851.83M |
| Institution ownership | 39.23% | Insider ownership | 18.100% |
| Earnings Date | 05/03/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -5.38 | Forward EPS | -2.38 |